[go: up one dir, main page]

DK95482A - Fremgangsmaade til fremstilling af aroylimidazoloner - Google Patents

Fremgangsmaade til fremstilling af aroylimidazoloner Download PDF

Info

Publication number
DK95482A
DK95482A DK95482A DK95482A DK95482A DK 95482 A DK95482 A DK 95482A DK 95482 A DK95482 A DK 95482A DK 95482 A DK95482 A DK 95482A DK 95482 A DK95482 A DK 95482A
Authority
DK
Denmark
Prior art keywords
aroylimidazolons
procedure
preparation
aroylimidazole
cardiotonics
Prior art date
Application number
DK95482A
Other languages
English (en)
Other versions
DK168627B1 (da
Inventor
R C Dage
F P Palopoli
R A Schnettler
J M Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK95482A publication Critical patent/DK95482A/da
Application granted granted Critical
Publication of DK168627B1 publication Critical patent/DK168627B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Luminescent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK095482A 1981-03-05 1982-03-04 Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf DK168627B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US24088981 1981-03-05
US31431281 1981-10-23
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (2)

Publication Number Publication Date
DK95482A true DK95482A (da) 1982-09-06
DK168627B1 DK168627B1 (da) 1994-05-09

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK095482A DK168627B1 (da) 1981-03-05 1982-03-04 Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf

Country Status (18)

Country Link
US (1) US4405628A (da)
EP (1) EP0059948B1 (da)
KR (1) KR890000765B1 (da)
AT (1) ATE16489T1 (da)
AU (1) AU557590B2 (da)
CA (1) CA1190550A (da)
DE (1) DE3267352D1 (da)
DK (1) DK168627B1 (da)
ES (2) ES510087A0 (da)
GB (1) GB2096600B (da)
GR (1) GR76518B (da)
HK (1) HK61686A (da)
IE (1) IE52387B1 (da)
IL (1) IL65137A (da)
MY (1) MY8600700A (da)
NO (1) NO157175C (da)
NZ (1) NZ199885A (da)
PH (1) PH18345A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
ZA855592B (en) * 1984-07-30 1986-03-26 Merrell Dow Pharma The preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
AU8212491A (en) * 1990-06-29 1992-01-23 Upjohn Company, The Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (da) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc Fremgangsmåde til fremstilling af guanylat-cyclase-c-agonister
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
BR112016002789A2 (pt) 2013-08-09 2017-11-21 Ardelyx Inc compostos e métodos para inibir transporte de fosfato
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
DE3267352D1 (en) 1985-12-19
IE820491L (en) 1982-09-05
AU8103782A (en) 1982-09-09
NO157175B (no) 1987-10-26
ES8402827A1 (es) 1984-03-01
ATE16489T1 (de) 1985-11-15
DK168627B1 (da) 1994-05-09
KR830009046A (ko) 1983-12-17
NO820686L (no) 1982-09-06
NZ199885A (en) 1985-04-30
MY8600700A (en) 1986-12-31
CA1190550A (en) 1985-07-16
ES8305352A1 (es) 1983-04-16
KR890000765B1 (ko) 1989-04-05
US4405628A (en) 1983-09-20
GB2096600B (en) 1985-06-05
PH18345A (en) 1985-06-05
IL65137A0 (en) 1982-05-31
IL65137A (en) 1987-02-27
EP0059948B1 (en) 1985-11-13
AU557590B2 (en) 1986-12-24
ES510087A0 (es) 1983-04-16
HK61686A (en) 1986-08-29
GR76518B (da) 1984-08-10
ES519254A0 (es) 1984-03-01
EP0059948A1 (en) 1982-09-15
IE52387B1 (en) 1987-10-14
GB2096600A (en) 1982-10-20
NO157175C (no) 1988-02-03

Similar Documents

Publication Publication Date Title
DK95482A (da) Fremgangsmaade til fremstilling af aroylimidazoloner
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
DK178379A (da) Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf
NO158741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere.
DK217481A (da) Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK641187A (da) Fremgangsmaade til fremstilling af vandfri alkansulfonsyre
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
NO864514D0 (no) Fremgangsmaate for fremstilling av thiazoloner.
DK12388A (da) Sialosylcholesterol, fremgangsmaade til fremstilling af og neuropatimiddel omfattende samme
DK280285D0 (da) Fremgangsmaade til fremstilling af ascorbinsyre
DK261482A (da) Maettede aminocyclitolderivater og fremgangsmaade til deres fremstilling
DK319982A (da) Fremgangsmaade til fremstilling af bicykliske forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
DE3686472D1 (de) Cardiotonische phenyloxazolone.
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
FI831914A7 (fi) Pyrimidinonien ja niiden happoadditiosuolojen valmistusmenetelmät.
DK258180A (da) Fremgangsmaade til fremstilling af pyridylaminotriazoler eller syreadditionssalte deraf
DK32390D0 (da) Fremgangsmaade til fremstilling af oxazolinoazetidinylhydromethylbutensyrederivater
IT8324141A0 (it) Preparato per la cura delle ustioni.
DK317681A (da) Fremgangsmaade til fremstilling af 2-amino-3(4eller 5)-py-phenol eller syreadditionssalte heraf
DK296783A (da) Fremgangsmaade til fremstilling af eburnanderivater eller syreadditionssalte deraf
DK71884A (da) Fremgangsmaade til fremstilling af sulfonamidgruppeholdige aryloxybenzoesyre-derivater

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed